With the rising adoption of checkpoint inhibitors and combination therapies, BAVENCIO’s market growth is driven by expanding indications and strategic partnerships. However, competition from KEYTRUDA and TECENTRIQ poses challenges, making differentiation through combination strategies key […]
Tag: DelveInsight Business Research
Global Interventional Neuroradiology Market to Cross USD 50 Billion by 2032
The increasing prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs), is the key factor fueling the demand for interventional neuroradiology. As these conditions become more common, there is a […]
TEPMETKO Continues to Strengthens its Position as a Leading METex14 Skipping NSCLC Therapy
With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but TEPMETKO’s once-daily dosing and efficacy profile offer differentiation. LAS VEGAS, March 6, […]
Global Biosensors Market to Show Positive Growth at a CAGR of ~8% by 2032
The rising prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and cancer is greatly boosting the demand for biosensors, as these conditions necessitate frequent monitoring for proper management. Likewise, the increasing need for point-of-care […]
XPOVIO Continues to Disrupt the Oncology Market with Expanded Indications and Strong Market Performance
With global cancer incidence rising and a strong clinical pipeline exploring combination therapies, the XPOVIO addressable market is expanding. Despite competition from CAR-T and novel therapies, XPOVIO’s oral administration and unique mechanism offer differentiation. LAS […]